# Claritev Corp > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Claritev Corp). ## Overview Claritev Corp is a U.S.-based healthcare technology and services company that helps payers and plan sponsors manage medical cost, payment accuracy, and revenue integrity. Its platform combines out-of-network cost management, provider network access, data and decision science, and business-to-business healthcare payments to improve transparency, affordability, and quality across the healthcare ecosystem. ## Products & services • Out-of-network cost management solutions • Payment and revenue integrity services • Data and decision science tools • Business-to-business healthcare payments • Provider network solutions • Claims intelligence and billing accuracy services - **Claims Intelligence Solutions** (35%) — Tools that help payers manage medical spend, billing accuracy, and claim payment integrity. - **Network Solutions** (30%) — Primary and complementary PPO network access and provider discount arrangements. - **Payment and Revenue Integrity** (20%) — Services that improve reimbursement accuracy and reduce payment errors across claims workflows. - **Data and Decision Science** (10%) — Analytics and proprietary data products used to support pricing, transparency, and cost management. - **Healthcare Payments and Other Services** (5%) — Transaction and payment-related services sold through healthcare payer channels. - Out-of-network cost management solutions - Payment and revenue integrity services - Data and decision science tools - Business-to-business healthcare payments - Provider network solutions - Claims intelligence and billing accuracy services ## Customers Claritev sells primarily to healthcare payers, especially ASOs, TPAs, health insurers, and regional or national plans that use its solutions to manage claims and medical costs. The end beneficiaries are employers, plan sponsors, and members, but the company’s direct commercial relationships are usually with intermediaries that administer health benefits and claims. It also serves government-sponsored health plans and some property and casualty or supplemental insurance customers where claims processing and billing accuracy matter. - **ASOs and TPAs** (primary) — They buy wholesale claims and network solutions to serve self-insured employer clients and reduce medical cost burden. - **Health insurers and Blue plans** (primary) — They use Claritev's network, payment integrity, and claims intelligence offerings to improve reimbursement accuracy and manage spend. - **Self-insured employers and plan sponsors** (primary) — They are the end customers behind the ASO channel and use the solutions to control healthcare costs and improve member access. - **Government-sponsored health plans** (secondary) — They buy cost-management and payment solutions to support public-plan administration and claims accuracy. - **P&C and supplemental insurers** (secondary) — They use bill review and claims-adjudication-related services where healthcare payment accuracy is important. - ASOs and TPAs buying wholesale solutions for employer health plans - Health insurers using network and claims cost management tools - Self-insured employers and plan sponsors seeking lower medical spend - Government-sponsored health plans needing payment accuracy and transparency - Payers and brokers/consultants that distribute Claritev's services - Property and casualty and supplemental insurers using bill review services ## Geography Claritev's business is primarily U.S.-focused, with its solutions sold nationally through payer and employer distribution channels. The company has begun expanding internationally as part of Vision 2030, but the filings emphasize that its core installed base, provider network, and client relationships remain centered in the United States. Geography matters because healthcare reimbursement rules, payer workflows, and provider networks are highly local, so expansion requires adapting products and operations to new markets. - United States is the core market and main revenue base - Solutions are distributed nationally through payer and ASO channels - International expansion is a stated strategic priority - Provider network scale is a U.S. competitive asset - New markets must fit similar healthcare cost and payment challenges ## Strategy Claritev's Vision 2030 strategy is to evolve from a claims-cost management provider into a broader technology and data insights company across healthcare. Management is prioritizing new products in the core, adjacent offerings that reuse its data and distribution channels, international expansion, and operational transformation to support growth and margin improvement. - **Grow core claims and network solutions** (short-term) — The company wants to deepen value from its installed base and improve monetization of existing client relationships. - **Expand adjacent products** (medium-term) — Using the same data and distribution channels can raise TAM without rebuilding the go-to-market model. - **International market entry** (medium-term) — New geographies could diversify revenue and apply the platform to similar healthcare affordability problems. - **Operational and financial transformation** (short-term) — Management is trying to improve execution, efficiency, and scalability as the company returns to growth. - Expand value and new products in core offerings - Launch adjacent products using existing data and distribution - Enter new geographies with similar healthcare challenges - Improve financial and operational excellence - Invest in innovation and advanced technologies - Strengthen the Claritev brand and talent base ## Risks Claritev is exposed to customer concentration risk because a small number of large clients account for a meaningful share of revenue, and losing a major payer could materially affect results. The company also faces execution risk in international expansion, cybersecurity and data privacy risk due to sensitive healthcare data, and regulatory risk because its services operate within complex payer and claims workflows. As a healthcare transaction and technology provider, it is also vulnerable to changes in reimbursement practices, client retention, and IT system reliability. - **Customer concentration** [high] — Two or three clients represented a large share of revenue in recent periods, so churn would hit revenue and operating leverage. - **International expansion execution** [medium] — The company is entering markets where it has limited operating history and may need localized products and staffing. - **Cybersecurity and privacy breach** [high] — The business processes sensitive healthcare and claims data, so a breach could disrupt operations and damage trust. - **IT system downtime or software license disruption** [high] — Clients rely on uninterrupted access for time-sensitive claims processing, so outages can trigger switching behavior. - Large-client concentration can cause outsized revenue loss if a payer churns - International expansion may fail if local healthcare workflows differ - Cybersecurity or privacy breaches could disrupt claims processing - Regulatory changes can alter payer workflows and service demand - IT outages or license issues could interrupt client access and processing ## Accounting Claritev's reported results depend heavily on revenue recognition judgments, especially where services are bundled across claims, network, and payment workflows. Investors should also watch goodwill and long-lived asset impairment, fair value measurements tied to warrants and debt-related items, and income tax estimates, all of which can move earnings without changing underlying operations. Because the company carries significant debt and has transformation costs, interest expense, extinguishment gains, and non-recurring charges can create volatility in reported profit. - **Revenue recognition** — Can shift revenue between periods and affect gross margin comparability - **Goodwill and long-lived asset impairment** — Could reduce earnings and book value materially - **Fair value measurements** — Can create earnings volatility unrelated to core operations - **Debt and interest expense** — Raises leverage burden and depresses net income - **Income taxes and transformation costs** — Can obscure underlying operating trend - Revenue recognition affects timing across bundled healthcare service contracts - Goodwill and long-lived asset impairment could affect reported equity and earnings - Fair value changes on warrants and founder shares can create non-operating volatility - Debt-related interest expense is significant and impacts net income - Income tax estimates and transformation costs can distort period comparability --- *Last updated: 2026-04-28T19:58:01.996242+00:00*